Ron Finklestien

Airline Stocks Set to Soar in 2024: A Look at Three High-Flyers

As we embark upon a new year, several airline stocks are catching the eye of investors, with a...

AMA’s Game-Changing Reimbursement Codes for Psychedelic-Assisted Therapies AMA’s Game-Changing Reimbursement Codes for Psychedelic-Assisted Therapies

The American Medical Association’s recent activation of the current procedural terminology (CPT) III codes marks a significant milestone for FDA-legalized psychedelic-assisted therapies, presenting an impactful stride for physicians and other...

Major Deal: TotalEnergies Finalizes €3.4B Transaction with Alimentation Couche-Tard TotalEnergies Finalizes €3.4B Transaction with Alimentation Couche-Tard

HJBC/iStock Editorial via Getty Images TotalEnergies (NYSE:TTE) has successfully concluded the sale of specific European retail assets to Alimentation Couche-Tard (OTCPK:ANCTF) for an impressive €3.4B, equivalent to approximately $3.8B. The deal included around $2.4B disbursed in December...

Opportunity Awaits: Agriculture Stocks to Buy for the New Year ...

Ripe for the Picking: A Bountiful Year for Agriculture Stocks After such an incredible year for the stock market...

What’s Happening with Trinity Place Holdings Stock? ...

Trinity Place Holdings Inc. TPHS shares are significantly surging on Wednesday after the company reported that its mortgage lender has extended the...

Xerox Implementing Workforce Reduction in New Operating Model

Xerox Holdings Corporation XRX witnessed a significant decline in its stock price following the announcement of a 15% workforce reduction as part of the company's new operating model.Business RestructuringWhat To Know: Xerox is embarking on a business restructuring...

CVS to ensure biosimilar coverage as it drops Humira from formularies CVS to ensure biosimilar coverage as it drops Humira from formularies

JHVEPhoto CVS Health (NYSE:CVS) has announced that it will remove AbbVie’s (NYSE:ABBV) blockbuster drug Humira from its major national commercial formularies on April 1 and instead provide coverage for biosimilars of the product. The healthcare conglomerate stated that...

Ralph Lauren’s Digital Surge: A Bullish Outlook for 2024 Ralph Lauren’s Digital Surge: A Bullish Outlook for 2024

Amidst bullish sentiments, Ralph Lauren Corporation (RL) is charting a course for growth, propelled by a remarkable digital surge and robust strategies. With a steadfast focus on enhancing digital capabilities, deepening customer relationships, and expanding in international markets...